Strata Critical Medical, Inc. (SRTA)
NASDAQ: SRTA · Real-Time Price · USD
5.26
+0.64 (13.85%)
At close: Dec 11, 2025, 4:00 PM EST
5.30
+0.04 (0.76%)
Pre-market: Dec 12, 2025, 7:00 AM EST
Strata Critical Medical Stock Forecast
Stock Price Forecast
The 2 analysts that cover Strata Critical Medical stock have a consensus rating of "Strong Buy" and an average price target of $7.63, which forecasts a 45.06% increase in the stock price over the next year. The lowest target is $7.25 and the highest is $8.00.
Price Target: $7.63 (+45.06%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Strata Critical Medical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|
| Strong Buy | 1 | 1 | 2 |
| Buy | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 |
| Total | 1 | 1 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Lake Street | Lake Street | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +52.09% | Dec 2, 2025 |
| Lake Street | Lake Street | Strong Buy Maintains $6.5 → $7.25 | Strong Buy | Maintains | $6.5 → $7.25 | +37.83% | Sep 17, 2025 |
Financial Forecast
Revenue This Year
190.46M
from 248.69M
Decreased by -23.42%
Revenue Next Year
265.20M
from 190.46M
Increased by 39.24%
EPS This Year
-0.09
from -0.35
EPS Next Year
0.08
from -0.09
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 199.9M | 283.5M | |
| Avg | 190.5M | 265.2M | |
| Low | 179.4M | 245.0M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -19.6% | 48.9% | |
| Avg | -23.4% | 39.2% | |
| Low | -27.8% | 28.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.09 | 0.08 | |
| Avg | -0.09 | 0.08 | |
| Low | -0.09 | 0.08 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.